BBI Solutions markets first chimeric Jo-1 HumAb IgG
BBI Solutions has launched a new Jo-1 human chimeric antibody for use as a calibrator or positive control in assays to diagnose conditions such as connective tissue disease (CTD). BBI has used cell culture technologies in response to the concerning situation, as hospital visits continue to be dominated by Covid-related cases, leading to a drop […]
